30.07.2014 23:08:07

BioMarin Pharma Q2 Loss Widens - Quick Facts

(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) Wednesday said second-quarter loss widened to $33.5 million or $0.23 per share from $21.5 million or $0.16 per share in the same period last year.

On average, 18 analysts polled by Thomson Reuters expected the company to report a loss of $0.42 per share for the quarter. Analysts' estimates typically exclude special items.

Adjusted earnings for the quarter were $10.8 million or $0.06 per share. BioMarin revenues increased 40.1 percent to $191.7 million from $136.8 million last year. Analysts expected revenues of $158.96 million.

Looking ahead to the fiscal 2014, the company currently projects revenues in the range of $745 million to $765 million, up from its prior guidance range of $650 million to $680 million. Analysts currently expect full-year revenues of $675.88 million.

Nachrichten zu Biomarin Pharmaceutical Inc.mehr Nachrichten

Analysen zu Biomarin Pharmaceutical Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Biomarin Pharmaceutical Inc. 59,00 -6,14% Biomarin Pharmaceutical Inc.